Genentech Oncology
GO BEYOND THE SCIENCE
Fostering Equitable Care
Everyone, regardless of circumstances, deserves access to the best possible healthcare. That’s why Genentech is committed to health equity, so everyone can attain their full potential for health and well-being.
In support of our 10-year vision to provide 3 to 5 times more benefit for patients at 50% less cost to society, our health equity strategy is based on three areas of focus:
Embed representation
in our clinical trials, research and development, commercial work, and customer engagement
Improve equitable access
by addressing barriers to accessible, affordable, high quality care for underserved patients
Build community trust
by listening and co-creating with community partners to address implicit bias and cultural stigma
Featured Initiatives
Working Toward Equitable Clinical Trial Enrollment
Genentech launched the Advancing Inclusive Research Site Alliance, a first-of-its-kind coalition of clinical research sites working to advance representation of diverse patient populations in clinical trials and establish industry-wide best practices.
View the full case study to learn more about our efforts on inclusive research.
Driving Cancer Screening Awareness to Improve Outcomes Among Black and Latina Women
Love Letters is a multicultural cancer screening awareness campaign focused on Black and Latina women. It uses the power of love to spread messages about the importance of cancer screening for women.
View the full case study to learn more about the Love Letters Campaign.
Other initiatives and resources include:
Bronzeville, Chicago & ACS Miles to the Horizon Health Equity Campaign
The 2022 Miles to the Horizon campaign, highlighting the Chicago neighborhood Bronzeville, is a regional initiative convened by the American Cancer Society (ACS). Genentech is proud to sponsor this innovative initiative aimed at providing awareness of local disparities facing marginalized communities in Bronzeville, IL.
The campaign included a geotargeted social media campaign promoting screening guidelines awareness within the community (Cook County, IL) reaching over 1.4 million virtual viewers and an in-person event, at a local community center convened by the local ACS. The Event screened the documentary video and brought in local organizations actively addressing disparities in the community.
Watch the documentary video created by ACS in partnership with the Apostolic Faith Church to learn more.
This project is an example of one of our many community engagements, solving difficult problems at the local level.
Contact us to learn how we're advancing health equity.
Partnering With the Association of Community Cancer Centers (ACCC) to Meet Patients Where They Are
We believe that representation of real-world patient populations is required to improve clinical outcomes for all patients. In collaboration with ACCC, we are working to expand access to innovative cancer treatment in the community, where 80% of cancer care takes place.1,2
We seek to place clinical trials in the local community to facilitate equitable recruitment, enrollment, and retention of a diverse patient population. We are also working to educate community oncologists so that they can provide up-to-date information on innovative modalities in clinical trials.
Learn more about the ACCC’s work to diversify clinical trial enrollment and engage with community oncologists.
Listening, Learning, and Building Trust in Flint, MI
Cancer rates in Genesee County, where the city of Flint is located, were determined to be significantly higher than anywhere else in the state. Genentech, partnered with National Minority Quality Forum (NMQF) and other community leaders, through a commercial sponsorship, to understand the problem and their needs around equitable access to cancer care, and mobilized resources to drive awareness and activate Flint residents to get routine cancer screenings.
The 2023 Flint Cancer Screening and Health Fair helped increase awareness about the importance of routine cancer screenings and how early detection may lead to improved outcomes. In 2023, the NMQF invited Genentech to a panel discussion of providers, patient/community advocates and research to discuss ways to effectively engage communities of color.
Learn more about our efforts to engage with the community and raise cancer screening rates in Flint.
Up next
Explore How We Can Advance Patient-Centered Care Together
-
-
Garg AK. Am J Clin Oncol. 2020;43(8):537-538.
Garg AK. Am J Clin Oncol. 2020;43(8):537-538.
-
Merkow RP, et al. JAMA Intern Med. 2019;179(8):1043-1051.
Merkow RP, et al. JAMA Intern Med. 2019;179(8):1043-1051.
-
-